Beranda › Leukemia Limfoblastik Akut › New York › New York City
Uji klinis Leukemia Limfoblastik Akut di New York City, NY
23 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Menerima pesertaStudi observasional
- Columbia University Medical Center, New York
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Menerima pesertaFase 1/2
- Montefiore Medical Center, New York
Cord Blood Transplant in Adults With Blood Cancers
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CTD402 in T-ALL/LBL Patients
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Menerima pesertaFase 1/2
- Research Site, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- dan 3 lainnya
A Study of Revumenib and Mezigdomide in People With Leukemia
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
European Prospective Investigation Into Childhood Cancer
Menerima pesertaStudi observasional
- Columbia University Irving Medical Center, New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 2
- Memorial Sloan Kettering, New York
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Menerima peserta
- Columbia University Medical Center, New York
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Menerima pesertaFase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Uji klinis Leukemia Limfoblastik Akut di kota lain
- Houston, TX28 studi
- Seattle, WA21 studi
- Baldwin Park, CA21 studi
- Chicago, IL20 studi
- Atlanta, GA19 studi
- Memphis, TN16 studi
- Washington, DC16 studi
- Philadelphia, PA16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Mountain View, CA13 studi
- Durham, NC13 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.